Location History:
- Creve Coeur, MO (US) (1978 - 1981)
- Chesterfield, MO (US) (1981)
Company Filing History:
Years Active: 1978-1981
Title: The Innovative Journey of Mau-Jung Kuo
Introduction
Mau-Jung Kuo, based in Creve Coeur, MO, has made significant contributions to the field of biomedicine through his inventive work. With a portfolio of 10 patents, Kuo has demonstrated a remarkable dedication to the advancement of scientific research, particularly in the area of angiogenic factors.
Latest Patents
Kuo's latest patents showcase his innovative approaches. One notable patent is focused on the production of angiogenic factor by cell culture. This process involves cultivating the human diploid cell line IMR-90 on a support surface in a nutrient culture medium at a temperature of approximately 35°-38°C. The result is the elaboration and recovery of angiogenic factors from the cells or cell products. Another significant patent details a method of culturing microcarrier supported cells, utilizing a submerged cell culture technique that incorporates microcarrier support made from cross-linked polystyrene resin beads, which are derivatized with amino acids, peptides, or hydroxy carboxylic acids.
Career Highlights
Throughout his career, Kuo has held positions at prestigious institutions, including Monsanto Company and Harvard College. His experience in these environments has undoubtedly influenced his research and innovative pursuits. His work has been recognized for its potential applications in therapeutic settings, particularly in regenerative medicine.
Collaborations
Kuo has worked alongside notable colleagues, including Joseph Feder and William R Tolbert. These collaborations have fostered a productive research environment, allowing for the cross-pollination of ideas and further innovation in their respective fields.
Conclusion
Mau-Jung Kuo's contributions to science and medicine are reflected in his extensive patent portfolio and collaborative endeavors. By continuously pushing the boundaries of research and technology, Kuo has positioned himself as a key figure in the innovation landscape, particularly concerning angiogenic factors and cell culture methodologies. His work continues to inspire advancements in biomedical research and has the potential to impact therapeutic applications significantly.